Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 3:20 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1033–1056 of 1,610 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FLD Clear all

Conditions: Breast Cancer
Interventions: Dual-Energy Contrast-Enhanced (DECE) mammography, digital mammography; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older · Female only
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: COVID-19
Interventions: Auricular percutaneous neurostimulation; Device
Lead sponsor: Olive View-UCLA Education & Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Sylmar, California

Conditions: Glioblastoma Multiforme, Gliosarcoma
Interventions: ZD6474, temozolomide, Radiation Therapy; Drug · Radiation
Lead sponsor: Patrick Y. Wen, MD; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 7
States / cities: Boston, Massachusetts • Detroit, Michigan • New York, New York + 2 more

Conditions: Acute Coronary Syndrome, Coronary Artery Stenosis, Myocardial Ischemia
Interventions: CardioFlux Magnetocardiograph; Diagnostic Test
Lead sponsor: Genetesis Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Detroit, Michigan • Royal Oak, Michigan

Conditions: Major Depressive Disorder
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 60 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Prostate Cancer
Interventions: Standard of Care MRI, Fluciclovine PET scan added to MRI; Device · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation (PAF)
Interventions: Sphere-9 Catheter Ablation; Device
Lead sponsor: Medtronic Cardiac Ablation Solutions; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 22
States / cities: Birmingham, Alabama • La Jolla, California • Los Angeles, California + 19 more

Conditions: Occipital Transcranial Magnetic Stimulation
Interventions: Sham TMS condition, OffLine TMS Condition, Online TMS condition; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid Use Disorder, Healthy Volunteers
Interventions: TMS (MagVenture MagPro 100 with MagOption); Device
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alzheimer Disease
Interventions: Active TMS, CILT, Sham TMS; Device · Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 60 Years to 85 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Gender Dysphoria
Interventions: Polyethylene Glycol 3350; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Dementia
Interventions: User-Led Meaningful Activity Plan; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 60 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Mild Cognitive Impairment
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Duke University; Other
Eligibility: 60 Years to 82 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: TBI (Traumatic Brain Injury)
Interventions: Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: San Diego, California

Conditions: Chronic Rhinosinusitis
Interventions: Propofol and Remifentanyl, Sevoflurane and Remifentanyl; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Mild Cognitive Impairment (MCI)
Interventions: real tACS, sham tACS; Other
Lead sponsor: High Point University; Other
Eligibility: 65 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Neuroendocrine Tumors, Prostate Cancer
Interventions: Single-Tracer FDG PET/CT Exam, Single-Tracer Cu64-DOTATATE PET/CT Exam, Single-Tracer Ga68-DOTATATE PET/CT Exam, Single-Tracer PSMA PET/CT Exam; Diagnostic Test
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Epilepsy
Interventions: MRI, MEG; Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 8 Years to 120 Years
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2028
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Major Depressive Disorder
Interventions: Intermittent Theta Burst Stimulation (iTBS); Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Radiodermatitis
Interventions: Norepinephrine; Drug
Lead sponsor: ProCertus BioPharm, Inc; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Chronic Pain, Back Pain, Pain
Interventions: Transcranial Magnetic Stimulation, Sham rTMS; Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Homonymous Hemianopia, Homonymous Quadrantanopia
Interventions: Reminder-cue scanning training; Behavioral
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 16 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gestational Diabetes Mellitus, Hypertension in Pregnancy, Dysglycemia
Interventions: OB Provider Clinical Decision Support (CDS), Patient Education (OB Visit), Text messaging, Patient Outreach, Primary Care Provider Clinical Decision Support (CDS), Patient Education (Primary Care Visit); Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2,306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Search by objective public record fields.

Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography

Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19

Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors

Use of Magnetocardiography in Evaluation of Patients Going for Cardiac Catheterization

Mini Theta Burst TMS in MDD Patients

Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

TMS of Visual Working Memory

Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder

Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease

Polyethylene-glycol Assisted Nerve Repair in Phalloplasty

User-Led Meaningful Activity and Early-Stage Dementia

Network-guided TMS in Early Alzheimer's Disease

Improving Functions in MTBI Patients With Headache by rTMS

Total Intravenous Anesthesia (TIVA) vs. Inhaled Anesthesia for Endoscopic Sinus Surgery.

Multi-session Transcranial Alternating Current Stimulation to Improve Dual-task Standing and Brain Activity in Older Adults With Mild Cognitive Impairment

Dual-Tracer Theranostic PET

Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

Targeting Specific Brain Networks to Treat Specific Symptoms in Depression

Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

Hippocampal Stimulation in Chronic Low Back Pain

Reminder-cue Scanning Training for Homonymous Visual Field Loss

Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)